North American Company for Life and Health Insurance Life Insurance Fit Review for People With Heart Disease

Research Snapshot

Why North American Company for Life and Health Insurance Qualified for This Study

Questions This Section Answers

• Is North American Company for Life and Health Insurance a good choice for life insurance for people with heart disease?
• Why did only two of seven AI platforms name North American Company for Life and Health Insurance for heart disease applicants?

North American qualified because it offers permanent life insurance products that can be structured for lifelong coverage, which matters to a buyer with a chronic cardiac condition. Two of seven platforms named it during ranking discovery, at an average listed rank of 9.0 and a best rank of 9 (anthropic, kimi). That is a minority of the included platform responses, so its presence in this study reflects relevance, not broad endorsement.

The company markets guaranteed universal life and indexed universal life, and independent reviews describe it as a contender for permanent coverage with complicated health histories ^[1]. One independent review states its underwriting tends to be more favorable for applicants with controlled chronic conditions ^[3]. Another describes its sweet spot as standard and standard-plus risk classes ^[4].

Those claims are platform-reported and not independently verified. The same evidence set also shows strict cardiac rules, which is why the fit rating is mixed rather than strong. This review evaluates North American only for the heart disease use case, not as a general company review. For the full field of carriers, see the Life Insurance for People With Heart Disease consensus index.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for People With Heart Disease

Questions This Section Answers

• Which North American Company for Life and Health Insurance plan should a buyer with heart disease choose if they need a guaranteed death benefit?
• Is Custom Guarantee GUL or Builder Plus IUL 4 better for a heart disease applicant who wants living benefits?

Custom Guarantee GUL is the most directly relevant product for a buyer who needs a death benefit intended to remain in force for life. It provides a lifetime guaranteed death benefit, selectable guarantee duration, and short-pay designs, and the cited product overview lists accelerated-death-benefit endorsements ^[5]. An independent review describes it as universal life with a no-lapse guarantee to age 120 ^[6].

Builder Plus IUL 4 is the relevant option for buyers who accept indexed universal life complexity. It is designed for death-benefit protection plus potential long-term cash-value accumulation, and its no-lapse guarantee depends on paying the specified premium requirement ^[8]. North American states Builder Plus IUL 3 can be offered with accelerated underwriting and possibly no labs or exams for eligible cases ^[10].

Platforms disagreed on whether a whole life product applies. The ranking recommendation referenced whole life, but independent reviews state North American does not sell whole life insurance ^[11]. A current whole-life product specifically matching this use case was not verified, so buyers should treat whole life as unconfirmed.

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree on about North American Company for Life and Health Insurance for heart disease applicants?
• Does North American Company for Life and Health Insurance offer living benefits that cover a heart attack?

Platforms broadly agreed on three points. First, the relevant products are permanent: Custom Guarantee GUL and Builder Plus IUL, with no platform identifying a heart-disease-specific program ^[14]. Second, living benefits explicitly include heart attack. North American's accelerated death benefit endorsement covers critical illness, and heart attack is listed as a qualifying condition ^[17]. One platform reported the benefit covers heart attack up to the lesser of 25% or $50,000, with higher limits on some IUL policies and an administrative fee ^[21].

Third, underwriting is individualized and cardiac history affects class placement. North American states pre-existing conditions can affect eligibility, policy type, and premium, and that underwriting considers diagnosis details, symptoms, hospitalization, medications, and severity ^[22]. Its underwriting guidelines describe traditional requirements and substandard ratings ^[23]. One guideline set excludes any diagnosis of arteriosclerotic vascular disease from a preferred tobacco class ^[24].

Agreement among platforms does not prove product quality. It reflects that the same public documents were available to each platform.

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• How strict is North American Company for Life and Health Insurance underwriting for moderate coronary artery disease?
• Can a heart disease applicant qualify for WriteAway accelerated underwriting with North American Company for Life and Health Insurance?

The sharpest disagreement concerns underwriting strictness. One platform reported that any history of heart disease disqualifies applicants from preferred classes, moderate coronary artery disease typically results in Table 4 or higher, and severe or early-onset disease is declined ^[25]. Another reported a 12-month postponement after myocardial infarction, Table 4-6 ratings at 12-24 months, and possible standard rates at five or more years with a normal ejection fraction ^[27]. A third described the company as having liberal underwriting for controlled chronic conditions ^[29]. These positions are not fully reconcilable from the supplied evidence.

Accelerated underwriting eligibility is also uncertain. WriteAway is limited by age, face amount, build, and medical-risk criteria, and the field guide allows the insurer to require an interview or labs ^[31]. Independent reviews describe no-exam coverage up to $2 million for ages 18-60, while another caps the no-exam pathway at $500,000 ^[32]. No source confirms a cardiac applicant will qualify.

Other unresolved items: no platform found a public cardiac rate table; the Custom Guarantee flyer is dated 2023 and should not be treated as current pricing; and product versions vary across Builder Plus IUL 3 and 4 ^[34].

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What features does North American Company for Life and Health Insurance offer that matter to a buyer with heart disease?
• Does North American Company for Life and Health Insurance let a policyholder switch from GUL to IUL without new medical underwriting?

The most use-case-relevant feature is the accelerated death benefit. North American's living benefits flyer states the endorsement provides benefits for critical, chronic, and terminal illness, and heart attack is a specified qualifying condition ^[36]. One platform reported the benefit accelerates up to 90% of the death benefit, or up to $1 million-$2 million depending on the plan, for a qualifying critical illness ^[38].

The second relevant feature is the Guaranteed Exchange Privilege on Custom Guarantee GUL, which one platform states allows a switch to an IUL product at the same risk class without new evidence of insurability ^[39]. That matters if health declines after purchase.

Financial strength is reported consistently. The Builder Plus IUL 4 brochure reports A.M. Best A+ affirmed August 13, 2025, S&P A+ affirmed May 15, 2025, and Fitch A+ assigned June 17, 2025, while noting ratings are opinions rather than guarantees ^[40]. Independent reviews report the same A+ ratings ^[41]. The company reported paying over $547 million in life insurance death claims in 2024 ^[42]. Ratings do not indicate cardiac eligibility.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does North American Company for Life and Health Insurance cost per month for a heart disease applicant?
• What surrender charges and fees apply to Custom Guarantee GUL or Builder Plus IUL 4?

No personalized premium can be verified from public materials, and pricing confidence is low across platforms. Premium depends on age, sex, face amount, product design, underwriting class, cardiac history, other health factors, and state ^[43].

The only concrete figures supplied are illustrative and dated. A 2023 Custom Guarantee agent flyer showed 10-pay annual premiums for a $500,000 death benefit guaranteed to age 120 ranging from $14,160 for a preferred 55-year-old female to $32,346 for a standard 65-year-old male ^[43]. One platform reported standard-class examples of roughly $14,000-$49,000 annually for $500,000-$1,000,000 face amounts at ages 55-65, with substandard ratings increasing costs significantly ^[45]. These are not cardiac-risk quotes.

On relative pricing, one independent review states universal life rates are 13% to 22% below the national average while term rates are 9% to 21% above average ^[44]. Another reports that substandard table ratings add 25% per table to the standard premium ^[47], and that the absence of a Standard Plus class on GUL pushes marginally substandard applicants into higher-cost tiers ^[48].

Fees and contract terms: surrender charges may apply during the surrender-charge period and vary by product, issue age, sex, underwriting class, and policy year ^[49]. Builder Plus IUL 4 has a 10-year surrender charge period, and Custom Guarantee GUL includes a Premium Recovery Endorsement at 15, 20, or 25-year anniversaries ^[51]. Current cost-of-insurance and interest rates are not guaranteed, and the planned periodic premium may not be sufficient to carry the contract to maturity ^[52]. One platform reported an administrative fee on accelerated death benefit elections ^[45].

Best Suited For

Questions This Section Answers

• Who is North American Company for Life and Health Insurance best suited for among heart disease applicants?
• Is North American Company for Life and Health Insurance worth it for a stable cardiac patient who wants permanent coverage?

North American is best suited to buyers with stable, well-documented cardiac histories who want permanent death-benefit protection and are willing to complete traditional underwriting. The strongest candidates are applicants five or more years past a cardiac event with a normal ejection fraction, and applicants with controlled atrial fibrillation, which one platform reports may qualify near standard rates ^[56].

It also suits buyers who value living benefits tied to cardiac events, since heart attack is a qualifying critical illness ^[57]. Buyers who want an indexed universal life design with potential cash-value accumulation and who understand policy-cost and lapse risks are a secondary fit ^[59].

A third group is buyers who want to compare a mainstream permanent carrier against impaired-risk specialists before deciding ^[60]. For these buyers, North American is one quote among several, not a default choice.

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose North American Company for Life and Health Insurance for life insurance with heart disease?
• Does North American Company for Life and Health Insurance offer guaranteed issue coverage for severe heart disease?

Buyers who need guaranteed acceptance or coverage without medical underwriting should look elsewhere. North American does not appear to offer guaranteed issue or graded benefit products for uninsurable cardiac patients; its portfolio focuses on underwritten permanent life products ^[61].

Buyers with recent major cardiac events, unstable symptoms, pending cardiac testing, or complex cardiovascular histories are also poor candidates until an independent impaired-risk broker compares multiple insurers ^[63]. One platform states severe coronary artery disease, disease diagnosed before age 35, or heart disease paired with other rated conditions generally results in decline ^[65].

Buyers seeking simple, low-cost temporary coverage are not a fit either. Term rates are reported 9% to 21% above average, and permanent coverage costs significantly more than term for an equivalent death benefit ^[66]. Buyers who want participating whole life with dividends must look elsewhere, since North American does not sell whole life ^[68].

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to North American Company for Life and Health Insurance for a recent heart attack?
• When should a heart disease buyer choose a guaranteed issue policy instead of North American Company for Life and Health Insurance?

Another carrier may be better in four situations. First, recent or severe cardiac events: one platform names Prudential and Lincoln as having shorter postponements or better table treatment, and another names Protective, Banner/Legal & General, and Prudential as offering more favorable early post-MI terms ^[70]. These are platform-reported comparisons, not verified outcomes.

Second, when the buyer cannot qualify for traditional underwriting. Guaranteed issue whole life from Mutual of Omaha, Gerber Life, and AIG accepts applicants ages 50-85 regardless of cardiac history, with coverage typically capped at $25,000 and a two-year graded benefit ^[72]. Simplified issue products may also be an option for moderate coverage without an exam ^[74].

Third, when the need is temporary. Term coverage may be better for income replacement or debt protection, though North American's term pricing is not competitive ^[75].

Fourth, when the buyer wants variable account options, which North American does not offer. Buyers comparing the broader market can start with the life insurance category directory.

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer confirm with North American Company for Life and Health Insurance before signing a contract?
• What cardiac details will North American Company for Life and Health Insurance underwriting require?

Ask whether the exact diagnosis, event date, procedures, ejection fraction, stress-test results, symptoms, medications, smoking status, and follow-up history will be considered, and whether the decision will be standard, table-rated, flat-extra, postponed, or declined. Confirm whether the cardiac history makes the applicant ineligible for WriteAway or other accelerated underwriting, and what records, cardiologist reports, ECGs, stress tests, echocardiograms, or labs are required ^[76].

For Custom Guarantee GUL, request the guaranteed premium schedule and guaranteed death-benefit duration. For Builder Plus IUL, request guaranteed and current values, cost-of-insurance assumptions, surrender charges, loan rates, and lapse-risk projections ^[79]. Confirm which riders are available in your state and whether accelerated benefits carry an administrative fee, benefit reduction, or certification requirement ^[81].

Also verify the exact product version being quoted, since Builder Plus IUL 3 and 4 differ ^[83]. Confirm the insurer's current financial-strength rating and the exact issuing entity. Ask what happens to the policy and death benefit if premiums are reduced, missed, borrowed against, or paid only at the minimum no-lapse level ^[84]. Finally, confirm whether the recommendation is based on a broker's comparison of multiple impaired-risk carriers rather than a single-company illustration.

Final AI Consensus Verdict

Mixed fit. North American has relevant permanent products, especially Custom Guarantee GUL for lifetime death-benefit guarantees and Builder Plus IUL 4 for buyers accepting IUL complexity. Living benefits that explicitly include heart attack are a genuine use-case advantage, and financial-strength ratings are consistently reported as A+.

However, the evidence does not show a distinctive advantage for applicants with heart disease. No platform found a public cardiac underwriting guide, approval range, table-rating schedule, or cardiac pricing example. Preferred classes exclude cardiovascular history, and platforms disagreed on how strictly moderate coronary artery disease is rated. Company-owned citations materially outnumber independent ones, so company claims should not be read as independently verified.

The practical path: use an independent impaired-risk life-insurance broker, obtain an informal underwriting assessment before applying, and compare the resulting offer against several carriers, including guaranteed issue alternatives if traditional underwriting is unavailable.

How This Review Was Produced

This review was produced from seven AI platform responses collected for the research date 2026-09-22. Each platform was asked which life insurance carriers are generally worth considering for applicants with heart disease and why. Two of seven platforms named North American during ranking discovery, at an average listed rank of 9.0 and a best rank of 9.

Platform fit ratings were: anthropic good; deepseek uncertain; google, grok, kimi, openai, and perplexity mixed. All included platforms evaluated fit, but platform mentions count only platforms that named the entity during ranking discovery. Citations are platform-reported evidence, not independently verified facts. The supplied URLs were collected from platform responses and were not independently validated by the writer stage.

Methodology Limitations

Several limitations apply. No publicly verifiable heart-disease-specific underwriting guide, approval range, table-rating schedule, or cardiac pricing example was found. A cardiac history may prevent accelerated underwriting and trigger medical records, testing, or full underwriting.

The cited Custom Guarantee pricing is agent-facing, dated September 2023, and based on preferred or standard underwriting rather than a cardiac impairment. Products and riders may not be available in every state, and North American is not licensed in New York according to the WriteAway field guide ^[86].

Platform-reported research dates differ from the authoritative run date: deepseek reported 2026-06-11 while the run date is 2026-09-22. Platform-reported dates are provenance metadata and do not independently prove freshness. Deepseek ran with search disabled, so its findings are model-reported rather than retrieved. Company-owned citations materially outnumber independent citations, and company claims are not independently verified. Conflicting product names, pricing, and capabilities were described rather than resolved.

See the broader Life and Health Insurance for Life Insurance for People With Heart Disease consensus index for comparisons across qualified options.